Term Name: iptacopan hydrochloride monohydrate
Synonyms: (2S,4S)-2-(4-Carboxyphenyl)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-1-ium chloride--water (1/1), 4-{(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl}benzoic acid hydrochloride hydrate, 4-{(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl}benzoic acid--hydrogen chloride--water (1/1/1), Fabhalta, iptacopan hydrochloride hydrate, LNP 023 hydrochloride monohydrate, LNP-023 hydrochloride monohydrate, LNP-023-AAB, LNP023 hydrochloride monohydrate, LNP023-AAB
Definition: The monohydrate form of iptacopan hydrochloride. It is a complement factor B inhibitor approved for the treatment of adults with paroxysmal nocturnal hemoglobinuria.
Ontology: ChEBI [CHEBI:229654]  ( EBI )

Relationships
is a type of: hydrate
has_part: iptacopan hydrochloride
has_role: complement factor B inhibitor immunomodulator